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Abstract
Background: Perioperative lidocaine treatment is commonly used in horses that undergo surgical treatment of
colic, to prevent or treat postoperative ileus and reduce the effects of intestinal ischaemia-reperfusion injury.
However, its clinical efficacy has not been evaluated in a large population of horses undergoing small intestinal
surgery. The aim of the current study was to evaluate whether systemic lidocaine administration reduced the
prevalence, volume and duration of postoperative reflux and improved rates of survival following surgical treatment
of small intestinal lesions. Data were collected as a part of two prospective studies investigating postoperative
survival of surgical colic patients admitted to a UK equine referral hospital during the periods 2004–2006 and
2012–2014. Kaplan-Meier plots of cumulative probability of survival and the log-rank test were used to compare
survival between horses that did or did not receive lidocaine. The Wilcoxon rank-sum test was used to compare the
total reflux volume and duration of reflux between the groups. A multivariable Cox proportional hazards model was
used to identify pre- and intraoperative risk factors for non-survival.
Results: Data from 318 horses were included in the final analysis. The overall prevalence of postoperative reflux
was 24.5 %. This was significantly higher (34.8 %) in horses admitted in 2012–2014 compared to the 2004–2006
cohort (16.7). Perioperative lidocaine treatment had no effect on total reflux volume, duration of reflux or rates of
postoperative survival nor was it a risk factor associated with altered postoperative survival. Variables identified to
be associated with increased risk of postoperative mortality included packed cell volume on admission (hazard ratio
[HR] 1.03 95 %, 95 % confidence interval [CI] 1.004–1.06, p = 0.024), heart rate on admission (HR 1.014, 95 % CI 1.
004–1.024, p =0.008) and duration of surgery (HR 1.007, 95 % CI 1.002–1.01, p = 0.008).
Conclusions: Lidocaine therapy had no effect on the prevalence of postoperative reflux, total reflux volume and
duration of reflux nor did it have any effect on postoperative survival in horses undergoing surgical management of
small intestinal disease for treatment of colic. There is a need for a well-designed multicentre, prospective
randomised controlled trial to fully investigate the efficacy of lidocaine across different hospital populations.
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Background
Postoperative ileus (POI) is a frequent complication in
horses that have undergone small intestinal surgery for
management of colic and it increases the risk of postop-
erative mortality [1–4]. In horses at high risk of POI or
where POI develops postoperatively, prokinetic drugs
are frequently used. Lidocaine, erythromycin, metoclo-
pramide, cisapride, mosapride, and bethanechol are
agents that have been evaluated as prokinetic drugs in
horses through clinical [5–11] or experimental (both in
vitro and in vivo) studies [12–16].
Lidocaine is a local anaesthetic agent, which has anti-
arrhythmic, analgesic and prokinetic properties when ad-
ministered systemically in humans [17–19]. Several
studies have also evaluated its effects in horses using in
vitro and in vivo models. Systemically administered lido-
caine has been found to have anti-inflammatory proper-
ties such as reduction of mucosal COX-2 expression and
neutrophil count in ischaemic-injured equine intestine
or amelioration of the negative effects of flunixin meglu-
mine on recovery of injured mucosa [14, 15]. Lidocaine
therapy has been proposed as a treatment option for
horses with inflammatory conditions of the gastrointes-
tinal tract including POI and recovery from ischaemic
injury [20] and the authors of the latter study
highlighted the need for further trials to evaluate its clin-
ical effectiveness.
Studies that have investigated the prokinetic properties
of lidocaine have reported conflicting results. A study that
compared the effects of mosapride, cisapride, metoclopra-
mide and lidocaine on jejunal motility in adult Thorough-
bred horses found improved jejunal motility in response
to cisapride, mosapride and metoclopramide but not with
lidocaine treatment [16]. Additionally, lidocaine adminis-
tration in normal horses that underwent laparotomy did
not result in increased jejunal motility [13] and in a separ-
ate study was also associated with prolonged faecal transit
time and reduced faecal output in normal horses [21].
More recent in vitro studies [22–24] reported positive ef-
fects of lidocaine on the contractility of smooth muscle
isolated from equine jejunum in ischaemia and reperfu-
sion injury models. The effect was found not to be specific
to lidocaine and smooth muscle contractility was induced
with other agents including mexiletine, bupivacaine, tetra-
caine and procaine [23]. Overall, limited evidence has
been found to support the use of perioperative lidocaine
as a therapy for POI [25]. Despite this, lidocaine therapy is
frequently used in horses undergoing surgical treatment
of colic. A recent survey of European Equine Internal
Medicine and Surgery Diplomates reported that lidocaine
was used intraoperatively in 50 % of cases and postopera-
tively in 67 % to prevent POI and was the drug of choice
for 79 % of respondents in the management of POI in
horses [26].
In the authors’ hospital, intravenous lidocaine has
become more frequently used in the perioperative
management of horses undergoing surgical manage-
ment of small intestinal lesions for treatment of colic,
and in particular horses at increased risk of POI. The
aim of the current study was to investigate whether
routine use of lidocaine in this population of horses
has had any effect on the prevalence, duration of
postoperative reflux and total reflux volume in horses,
and to determine whether it has altered rates of post-
operative survival or is a risk factor for altered post-
operative survival.
Methods
Study population
The study population consisted of two cohorts of
horses that underwent surgical treatment of colic re-
lated to a primary small intestinal lesion at a UK
equine hospital. Horses were recruited onto the study
if they underwent exploratory laparotomy for treat-
ment of colic, were diagnosed with a small intestinal
lesion at surgery, and stood in the recovery box fol-
lowing general anaesthesia. The first cohort were
horses admitted in October 2004–November 2006,
when lidocaine was only used intermittently in colic
patients, and the second cohort was admitted in
October 2012–November 2014 after lidocaine use had
become implemented more routinely in horses under-
going small intestinal surgery for treatment of colic
based on studies published between the two time
periods advocating its use [3, 11, 20]. Routine surgical
and postoperative management of colic patients dur-
ing this time remained otherwise unchanged. Briefly,
this consisted of intravenous flunixin meglumine
administration for a minimum of 72 h (1.1 mg/kg
bwt q. 12 h), and antimicrobial therapy with procaine
penicillin (12 mg/kg bwt i.m. q. 12 h) or procaine
penicillin and gentamicin (6.6 mg/kg bwt i.v. q. 24 h)
for 3–5 days based on the surgical procedure per-
formed (e.g. enterotomy, resection and anastomosis)
and clinician preference. In this group of horses that
had primary small intestinal lesions, all received intra-
venous fluid therapy (lactated Ringer’s solution) for at
least the first 24 h postoperatively (unless they were
able to tolerate oral fluids prior to this), and until
oral fluid therapy could be initiated. Intravenous
fluids were administered according to maintenance re-
quirements (2 ml/kg bwt/h) together with additional
fluid losses (e.g. net reflux volume) and were supple-
mented with calcium and potassium where required.
Nasogastric intubation was performed at 2–4 hourly inter-
vals once postoperative reflux developed. This continued
until reflux ceased and oral water and feed were then
gradually reintroduced over 3–4 days. Where reflux
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persisted, repeat laparotomy was undertaken or horses
were euthanased based on lack of response to treatment
and/or owner finances. Monitoring of small intestinal mo-
tility and diameter was performed ultrasonographically in
some horses. Lidocaine therapy was usually administered
during anaesthesia and immediately following placement
in the stable following recovery from anaesthesia for most
horses in the 2012–14 cohort unless clinician preference
or lack of client finances dictated otherwise.
Data collection and follow-up
Preoperative data were collected in a specifically de-
signed colic admission form, which included questions
about signalment, use, current management practices
and any recent management changes, and results of clin-
ical and clinicopathological examinations (Additional file
1). Postoperatively, clinical parameters including the net
volume of reflux obtained and medications administered
were recorded in specifically designed hospital forms.
For both cohorts, survival was monitored following hos-
pital discharge by telephone questionnaires administered
with the horse owner/carer. This was performed every
3 months following discharge for the first 12 months
and then at 6 monthly intervals. The questionnaires
were administered as a part of two separate prospective
studies investigating postoperative survival following
colic surgery [27] and Salem et al. (unpublished data).
All data were entered onto a Microsoft access or a
Microsoft SQL Server database for the 2004–2006 and
2012–2014 cohorts respectively.
Administration of lidocaine intra- or postoperatively
was recorded based on examination of the anaesthetic and
postoperative monitoring sheets. The standard dose used
at the hospital was a 1.3 mg/kg bolus given intravenously
over 15 min followed by a 0.05 mg/kg bwt/min intraven-
ous continuous rate infusion (CRI). Due to the fact that it
is difficult to confirm true POI and to differentiate it from
other causes of small intestinal obstruction e.g. mechan-
ical obstruction that may occur postoperatively [28, 29],
the term postoperative reflux (POR) [30, 31] was used in
the current study. This was defined as a net nasogastric
reflux of ≥2 l on at least two consecutive occasions within
24 h postoperatively [32]. Due to the fact that pain was
not assessed using a single, consistent scoring system, we
could not assess the effect of lidocaine on postoperative
pain and this was not one of the aims of the current study.
Data analysis
Descriptive data analysis
Survival time was calculated as a continuous variable
starting from the date of surgery until the date of death
or censoring. Horses were censored if they were lost to
follow-up or were alive at the last interview date. Sur-
vival time was used to construct Kaplan-Meier plots of
cumulative probability of survival and the log-rank test
was used to compare survival between different surgical
diagnosis categories, and between horses that did or did
not receive lidocaine CRI intra- or postoperatively. A
chi-square test of independence was used to compare
frequencies of common surgical diagnosis categories and
surgical procedures performed such as intestinal resec-
tion and anastomosis or types of anastomosis performed,
use of prokinetic therapy and prevalence of POR be-
tween the two cohorts. The Wilcoxon rank-sum test was
used to compare number of days that the horses were
classified as having POR and total reflux volume be-
tween horses that received or did not receive lidocaine
CRI intra- or postoperatively. Horses diagnosed with
equine grass sickness (EGS) were excluded from statis-
tical analyses [33].
Univariable analysis
Explanatory variables were screened for univariable as-
sociation with time to death or censoring using uni-
variable Cox proportional hazards models. Variables
that had a likelihood ratio test (LRT) p value <0.25
were considered for inclusion into a multivariable
model. Variables containing ≥30 % missing data were
initially excluded from the analysis and categorical var-
iables with few observations in some categories were
re-categorised into fewer, biologically plausible categories.
Pearson’s correlation coefficient was used to test for col-
linearity between explanatory variables. If variables were
highly correlated (r ≥ 0.7) [34] or were considered to be
measuring the same exposure, the variable that resulted in
a greater reduction in residual deviance was selected [35].
The functional form of the relationships between continu-
ous predictor variables and survival time was explored
using penalized regression models [36]. The results from
these models were examined graphically and variables that
demonstrated a significant non-linear association with
survival were fitted as P-spline smoothers, otherwise a
linear fit was chosen. Data pre-processing and re-
categorisation were performed using Epi Info71 software.
Survival analysis was performed using the ‘survival’ statis-
tical package (version 2.38.1) [37] in R software environ-
ment version 3.2.2 [38]. Critical probability was set at 0.05
for all analyses.
Multivariable analysis
A multivariable Cox proportional hazards model con-
sidering only variables measured pre- and intraopera-
tively was built using a forward stepwise selection
procedure. Variables were added sequentially into the
model and were retained if they significantly improved
model fit. This was indicated by a LRT p value <0.05 and
a reduction in Akaike information criterion by at least
2 (ΔAIC >2) when nested models were compared.
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Eliminated variables were then forced back into the final
model to assess for confounding and two-way interac-
tions between variables remaining in this model were
evaluated for statistical significance. The proportional
hazard (PH) assumption was evaluated by plotting
complementary log-log survival curves and scaled
Schoenfeld residuals for variables remaining in the
model. This was also assessed statistically using the
Therneau-Grambsch non-proportionality test [39] as
implemented by the ‘survival::cox.zph’ function in R.
Scaled changes in regression coefficients associated
with the exclusion of individual data points (delta-
betas) were plotted in order to identify influential ob-
servations. The model was re-run following removal
of any influential data point (−0.4 < delta-betas > 0.4)
to evaluate their leverage on parameter estimates.
Poorly fitted data points were also evaluated in a de-
viance residual plot. A data point was considered out-
lying if the corresponding deviance residual value is
outside the range of (−2.5–2.5) [40]. The effect of
surgeon and of anaesthetist on the probability of sur-
vival was tested in the final model by including each
of these variables as a frailty term (random effect) in
the final model.
Results
Of 342 horses that underwent laparotomy for treatment
of a primary small intestinal lesion, 318 were recruited
onto the study (24 horses were excluded due to a diag-
nosis of EGS). The follow-up periods were the same for
both study cohorts and all interviews were concluded
approximately 3 months following the last recruitment
date. This resulted in 272.6 horse years of recorded sur-
vival time. The number of horses in each study cohort
and the frequencies of the most common surgical diag-
nosis categories and anastomoses types if small intestinal
resection was performed are shown in Table 1. There
was a significant increase in number of horses diagnosed
with idiopathic focal eosinophilic enteritis (IFEE) lesions
in the 2012–2014 cohort compared to the 2004–2006
cohort (19.7 vs 7.2 %). Surgical management of these le-
sions also varied: 78.6 % (11/14) of horses diagnosed
with IFEE lesions in 2004–2006 admission years had in-
testinal resection and anastomosis during surgery com-
pared with none in 2012–2014 admission years. There
was a significant reduction in the frequency of horses in
which intestinal resection and anastomosis was per-
formed, particularly the frequency of side-to-side jejuno-
caecal anastomosis in recent admission years.
Table 1 Results of descriptive data analyses comparing the two study cohorts
Diagnosis/types of small intestinal anastomosis/prokinetic
drugs/postoperative reflux
2004–2006 admission years 2012–2014 admission years χ2
p value
Total
Horses diagnosed with small intestinal lesions 195 (60.6) 147 (55.7) 0.23 342 (58.4)
Common diagnosis categories
Pedunculated lipoma obstruction 52 (25.7) 39 (26.5) 0.98 91 (26.6)
Idiopathic focal eosinophilic enteritis 14 (7.2) 29 (19.7) 0.001 43 (12.6)
Epiploic foramen entrapment 29 (14.9) 14 (9.52) 0.14 43 (12.6)
Ileal impaction 11(3.2) 13 (3.8) 0.7 24 (7)
Equine grass sickness (EGS) 15 (7.7) 9 (6.1) 0.6 24 (7)
Horses undergoing intestinal resection and anastomosis
(EGS cases excluded)
115 (63.9) 56 (41.8) <0.001 171 (54.5)
Side-to-side jejunocaecal anastomosis 42 (24.3) 12 (9) 0.001 54 (17.2)
Side-to-side ileocecal anastomosis 3 (1.7) 0 (0.0) - 3 (0.96)
Side-to-side jejunojejunal anastomosis 4 (2.2) 0 (0.0) - 4 (1.3)
End-to-end jejunoileal anastomosis 9 (5) 15 (11.2) 0.04 24 (7.6)
End-to-end jejunojejunal anastomosis 57 (31.7) 29 (21.6) 0.049 86 (27.4)
Prokinetic drugs used (EGS cases excluded)
Lidocaine CRI intraoperatively 25 (16.1) 86 (62.3) <0.001 111 (37.9)
Lidocaine CRI postoperatively 7 (4) 102 (73.9) <0.001 109 (34.8)
Metoclopramide 1 (0.6) 9 (6.5) - 10 (3.2)
Erythromycin 0 (0.0) 7 (5.07) - 7 (2.2)
Lidocaine CRI plus Metoclopramide 0 (0.0) 8 (5.8) - 8 (2.5)
Postoperative reflux (EGS cases excluded) 30 (16.7) 48 (34.8) <0.001 78 (24.5)
Results of descriptive data analyses comparing frequencies of small intestinal lesions, common diagnosis categories, types of small intestinal anastomosis performed,
prokinetic drugs administered intra- or postoperatively, and postoperative reflux between the two study cohorts. Chi-square (χ2) test p values comparing these frequencies
and total frequencies are shown. Descriptive data are presented as numbers (%)
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Cumulative probabilities of survival of horses in the
five most frequent diagnosis categories are shown in
Fig. 1a. IFEE and ileal impaction cases had a fairly stable
survival at around 0.8 throughout the study period. This
was in contrast to epiploic foramen entrapment (EFE)
cases, which demonstrated a rapid decline in postopera-
tive survival resulting in a median survival time of
370 days. The log-rank test of the probability of survival
between these small intestinal lesions was significant at
p = 0.038. Cumulative probability of survival did not dif-
fer significantly between horses in the two study cohorts
(log-rank test p = 0.79) (Fig. 1b).
Effect of lidocaine therapy
The prevalence of POR in all horses recruited onto the
study was 24.5 %. This was significantly higher in horses
admitted in 2012–2014 (34.8 %) compared to 16.7 % in
horses admitted in 2004–2006 (Table 1). POR resulted
in a significant reduction in the long-term probability of
survival and this effect was evident throughout the
follow-up period (Fig. 2a). There was no statistical evi-
dence that intraoperative lidocaine administration had
any effect on long-term postoperative survival (log-rank
test p = 0.72) (Fig. 2b). Because postoperative lidocaine
treatment was not assigned randomly and horses were
administered this medication if they were considered to
be at high risk of developing POR or occasionally once
horses had developed POR, the data were stratified and
the effect of lidocaine CRI on probability of survival was
compared in horses that did or did not develop POR
separately. Such comparison did not reveal any signifi-
cant improvement in the probability of survival in
lidocaine-treated horses (Fig. 2c and d). The median
duration of POR and of total reflux volume did not
Fig. 1 Kaplan-Meier plots comparing commonly identified small intestinal lesions (a) and the study cohorts (b). Kaplan-Meier plots of cumulative
probability of survival and the log-rank test were used to compare survival between the five most frequent surgical diagnosis categories and between
horses that belong to each of the admission periods (2004–2006 and 2012–2014 admission years). Vertical lines on the curves represent censoring
times. The log-rank test p values and number of horses in each category are shown. EFE = epiploic foramen entrapment, IFEE = idiopathic focal eosino-
philic enteritis, PLO = pedunculated lipoma obstruction
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differ significantly between horses that were or were not
administered intraoperative (Wilcoxon rank-sum p =
0.75 and 0.86 respectively) or postoperative lidocaine
therapy (Wilcoxon rank-sum p = 0.15 and 0.14 respect-
ively) (Fig. 3).
Risk factors for postoperative survival
Results of univariable analysis of continuous and categor-
ical variables are available in Additional files 2 and 3. The
functional form of the relationships examined by penal-
ized regression models was non-linear for the variable
heart rate on admission and therefore, this variable was
evaluated as a penalized smoothed term in the multivari-
able model (Fig. 4). A final multivariable proportional haz-
ards model is shown in Table 2. Variables identified to be
associated with increased risk of postoperative mortality
included packed cell volume on admission, heart rate on
admission and duration of surgery. There was a significant
multiplicative interaction between duration of surgery and
EFE (hazard ratio 1.013, 95 % confidence interval 1.002–
1.03, p = 0.027), meaning that the hazard ratio comparing
horses with or without EFE depends on the duration of
surgery. The random effects of surgeon and of anaesthetist
tested in the final model were not significant (p = 0.98).
The proportional hazards assumption was satisfied in
the final multivariable model (global p value from the
Therneau-Grambsch non-proportionality test = 0.94). A
single influential data point was identified for variable
PCV on admission (Additional file 4). The observations
had a censored survival time, yet it was from a horse
that had a PCV of 74 % on admission. Removal of this
influential observation and re-running the model re-
sulted in 33 % increase in the regression coefficient of
this variable. The observation was found to be accurately
recorded, so it was retained in the model. Four poorly
fitting data points were identified on a deviance residual
plot (Additional file 5). They had deviance residual values
of >2.5 and the values were positive which meant observed
death happened before the model was able to predict it.
These observations were from horses that had PCV on
admission of ≤40 % and surgery duration of ≤105 min, yet
they had a survival time of 1 day.
Fig. 2 Kaplan-Meier plots illustrating the effect of POR and of lidocaine therapy on postoperative survival. Kaplan-Meier plots of cumulative probability
of survival and the log-rank test were used to compare survival between horses that developed or did not develop postoperative reflux (a), horses that
received or did not receive lidocaine CRI intraoperatively (b). Following stratifying the data by postoperative reflux, the effect of postoperative lidocaine
therapy was assessed in horses that developed (c) or did not develop postoperative reflux (d). The number of horses in each category and the
log-rank test p values are shown
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Discussion
The current study found no significant effect of intra- or
postoperative lidocaine therapy on the duration of POR
or total reflux volume in horses that underwent laparot-
omy for treatment of small intestinal lesions. Lidocaine
administration also had no significant effect on postop-
erative survival, consistent with the findings of Malone
et al. [11]. Lidocaine is currently commonly adminis-
tered postoperatively in horses that have undergone sur-
gical management of colic based on its perceived
prokinetic properties [26]. These findings are important
and demonstrate the need for further evaluation of the
efficacy of lidocaine treatment in horses undergoing sur-
gical management of colic related to small intestinal dis-
ease, particularly in horses at high risk of or that have
developed POR, in a randomised controlled trial.
The prevalence of POR in the current study is compar-
able to previously reported rates of 9–33 % [3, 41–43].
The frequency of intra- or postoperative lidocaine treat-
ment was significantly greater in horses that underwent
surgical treatment of small intestinal lesions in 2012–2014
cohort, but the prevalence of POR doubled compared with
the 2004–2006 admission years (34.8 vs 16.7 %), which
was unexpected. The frequency of horses that were recov-
ered from surgery that had undergone intestinal resection
and anastomosis, particularly side-to-side jejunocaecal
anastomoses was also significantly reduced in the 2012–
2014 admission group. This is likely to be due to
awareness of the effects of intestinal resection and anasto-
mosis and of side-to-side jejunocaecal anastomosis on re-
duced postoperative survival, leading to some owners
choosing to have horses euthanased on the operating table
rather than continue with treatment or in equivocal cases,
surgeons choosing not to resect potentially viable small in-
testine [27, 44–46]. It is not possible to determine why the
prevalence of POR was increased in the 2012–2014 surgi-
cal cohort who routinely received perioperative lidocaine
therapy, nor to attribute it directly to lidocaine use as this
was not a randomised study. However, surgeons being
more likely to leave small intestine that would undergo
ischaemia-reperfusion injury may have resulted in in-
creased prevalence of POR in the 2012–2014 cohort. The
prevalence of IFEE lesions did differ between the two
study periods which could have resulted in bias. Fur-
ther exploration of the data using univariable and
multivariable models with POR as the outcome dem-
onstrated that the variable IFEE was not significantly
associated with POR (p = 0.58) and inclusion of IFEE
cases were therefore considered unlikely to have a
significant impact on the study. In addition, whether
resection was performed or not in IFEE cases was
considered unlikely to alter the likelihood of postop-
erative mechanical obstruction occurring (and subse-
quent development of POR) as these are thickened
lesions that cause acute colic due to simple obstruc-
tion at the site, and any physical thickening of
Fig. 3 Boxplots demonstrating the effects of lidocaine therapy on duration of POR and total reflux volume. Duration of postoperative reflux (POR)
and total reflux volume were compared between horses that were administered lidocaine continuous rate infusion postoperatively (a and b) or
intraoperatively (c and d). The box represents the 25th and 75th percentiles of the data, the horizontal line across the middle of the box
represents the median and the dot is the mean. Post-op = postoperatively, Intra-op = intraoperatively
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intestine at the site of IFEE lesions left in situ (i.e.
not resected) is comparable to that of an anastomosis.
In humans, systematic reviews and meta-analysis of ran-
domised clinical trials have investigated the prokinetic and
analgesic properties of lidocaine. Following open abdom-
inal or laparoscopic surgery in adult humans, lidocaine
has been found to be associated with significant reduc-
tions in postoperative pain scores [17, 47, 48]. However,
the evidence for prokinetic efficacy is variable. Evidence of
reduced time to first flatus, time to first bowel movement
or likelihood of POI was found to be of low quality [17].
Comparison of the efficacy of 15 systemically acting proki-
netic drugs for treatment of POI versus placebo in another
systematic review reported that only lidocaine and neo-
stigmine have an effect on gastrointestinal recovery in the
form of reduction of time to first flatus and to first bowel
movement [19]. Lidocaine treatment was also reported to
be associated with reduced duration of hospital stay and
of ileus following abdominal surgery in another systematic
review [49].
The prokinetic properties of lidocaine have been
evaluated previously in equine surgical colic patients
in two separate randomised clinical trials [10, 11]. In
one of these trials most of the horses were diagnosed
with large intestinal lesions at surgery (20/28) and
only two horses developed POI (one control, one
treatment), and therefore the prokinetic properties of lido-
caine could not be assessed [10]. In the study by Malone
et al. [11], lidocaine administration to horses that devel-
oped nasogastric reflux resulted in significant reduction in
number of horses refluxing at 30 h post-treatment and in
duration of hospital stay compared to saline group. The
study, however, did not report any differences in survival
to hospital discharge or in the level of postoperative pain
between groups. Limitations of the latter study include the
fact that the study was performed on a small number of
horses and included horses diagnosed with proximal
duodenitis-jejunitis (DPJ) treated medically (8 DPJ and 24
POI horses), which are lesions with different pathobiology
and relevance when considering lidocaine use in horses
that have undergone small intestinal surgery [25]. A
prophylactic effect of lidocaine in horses with POI was re-
ported in a study by Torfs et al. [3]. In the latter study,
lidocaine was frequently administered concurrently with
Fig. 4 Plots of P-spline smoothers of continuous pre- and intraoperative variables. Penalised regression models were used to investigate the functional
form of the relationships between the log hazard of postoperative death and continuous variables measured pre and intraoperatively. The plots show the
fitted curves with 95 % confidence intervals (dashed lines) and the rug plots along the x-axes represent the number of data points. Dotted horizontal lines
are at log hazard of zero. The p values are from chi square tests for non-linearity where a significant p value (p >0.05) indicates a non-linear association
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other prokinetic drugs such as metoclopramide and this
was not taken into account in the analysis of the data.
Therefore, the evidence for the use of perioperative lido-
caine to improve intestinal motility in horses at high risk
of developing POI remains of low quality [25] and sup-
ports the need for further investigation.
We acknowledge that one of the key limitations to this
study is the fact that horses were not randomly assigned
to lidocaine treatment. Lidocaine was instead assessed as
an intervention, as this was the only major change in
management of horses undergoing surgical treatment of
small intestinal lesions causing colic in the study hospital
between the two study periods. Other factors that may
have differed between the two time periods and may
have had a potential effect include the effect of surgeon
and anaesthetist, but they were assessed in the model
and were not significantly associated with outcome. It is
also important to note that economic factors may influ-
ence the decision to perform surgery or to recover
horses following general anaesthesia [50, 51] and conse-
quently this may introduce bias into survival models.
The costs of treatment, including lidocaine therapy, may
have been a limiting factor for some owners, particularly
when postoperative reflux persisted for a number of days
with no evidence of clinical improvement. It is, there-
fore, possible that with longer duration of therapy that
some of these horses may have survived. We did not
specifically investigate whether insurance cover had an
effect on the surgical outcome. However, we have previ-
ously found this to have no effect on survival of horses
recovered following surgery (unpublished hospital data)
and the estimated costs of treatment are the same re-
gardless of whether the horse is insured or not. It is also
important to note that the effect of lidocaine on postop-
erative pain could not be assessed due to lack of consist-
ent scoring in pain. This was not one of the key aims of
the present study, but the analgesic effects of lidocaine
should also be taken into consideration in future pro-
spective trials evaluating its use in horses following in-
testinal surgery for colic.
In the current study, horses that underwent surgery
for treatment of ileal impaction had the greatest prob-
ability of survival which is consistent with previous stud-
ies [43]. IFEE lesions were also associated with high
rates of postoperative survival, with a relatively stable
probability of survival at around 0.8 throughout the fol-
low-up period. In contrast, EFE had a poor prognosis
for survival with a median survival time of 370 days,
which is again consistent with previous studies [4, 33,
43, 52]. In the current study, PCV and heart rate
measured on admission and prolonged surgery dur-
ation were significantly and positively associated with
postoperative mortality. PCV and heart rate can be
markers for the degree of dehydration and systemic
inflammatory response syndrome (SIRS)/endotoxaemia
on admission [35]. This emphasises the importance of
early diagnosis and treatment of equine surgical colic
patients before development of marked physiological
derangements/SIRS in order to maximise the prob-
ability of survival following laparotomy.
Conclusions
In the current study, we found no effect of lidocaine
therapy on frequency of POR, duration of reflux, nor
was it a risk factor for, or associated with altered
rates of postoperative survival. Despite the frequent
use of lidocaine as a prokinetic agent in horses that
develop or are at high risk of POI, the evidence for
this still remains limited. Lidocaine therapy can add
significantly to treatment costs making it important
to fully evaluate the efficacy and cost-benefits of this
drug. There is a need for a prospective, multicentre
randomised clinical trial of lidocaine in horses with
small intestinal lesions that has sufficient statistical
power with well-defined inclusion criteria. There
should also be a well-defined set of outcome mea-
sures including accurate measurement of POR dur-
ation and total reflux volume and use of objective
and validated measures of postoperative pain, postop-
erative survival and complications.
Table 2 Multivariable Cox proportional hazards model of variables associated with reduced likelihood of survival
Variable Coefficient Standard error Hazard ratio 95 % CI of the hazard ratio p value
Packed cell volume on admission (%) 0.032 0.014 1.033 1.004–1.06 0.024
Heart rate on admission (beats/min) “the linear effect” 0.014 0.005 1.014 1.004–1.024 0.008
Duration of surgery (min) 0.0066 0.0025 1.007 1.002–1.01 0.008
Epiploic foramen entrapment Ref
No −0.66 0.77 0.52 0.1–1.35 0.39
Yes
Surgery duration × EFE 0.013 0.006 1.013 1.002–1.03 0.027
The data are from 318 horses that survived following laparotomy for treatment of small intestinal lesions; only 302 horses were included in the model due to
missing data for some variables. The model is adjusted for the non-linear relationship between heart rate on admission and probability of survival. CI confidence
interval, Re reference category
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